FDA Investigator Nayan J Patel

Nayan J Patel has inspections in 8 countries as of 27 Oct 2023. Nayan J Patel has collaborated with a combinined 5085 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
66
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100000343
Country:
Korea (Republic of), United States of America, Germany, India, Japan, China, Italy
Co-Investigator(s):
Aaron J Adler, Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Alicia A Armijo, Amir Alavi, Anastasia M Shields, Andrea A Branche, Andrea George, PhD, Andrea J Schmidt, Andrea S Heise, Andrew J Gonzales, Andrew Le, Andrew M Kolenc, Angel K Sandhu, Angele C Smith, Anh M Lac, Anthony E Keller, RPh, Anthony J Lagreca, April C Inyard, April L Young, Arsen Karapetyan, Ashleigh P Barkans, Ashleigh P Wodushek, Ashley N Queen, PhD, Barbara J Wilcox, PhD, Bichsa T Tran, Binh T Nguyen, Bonita S Chester, Brandon K Lawson, Bruce H Mccullough, Bryan A Galvez, Bryce A Hammer, Calvin B Koerner, Carl Lee, Carla J Lundi, Carla R Hinz, Carlos Chavez, Carole L Jones, Caroline H Le, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, Cassandra L Abellard, Christine I Shaw, Christine L Williams, Christopher M Jenner, Christopher R Czajka, Constantin Y Philopoulos, Cynthia Jim, CSO, Daniel J Lahar, Daniel J Roberts, Daniel Pst Laurent, Darren S Brown, David A Gonzalez, David D Anderson, PhD, David G Whitman, Debra I Love, Debra L Curtis, Diane Cvan Leeuwen, Diane L Raccasi, Dogbeda F Mackenzie, Dongping Dai, PhD, Dr. Chunchang Fang, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Duc Minh H Nguyen, Dustin M James, Dustin R Abaonza, Edith M Gonzalez, Eileen T Dupont, Elaine G Stewart, Elisa J Beard, Emily Shacter, Eric L Dong, BS, Erika V Butler, Felix J Marrero, Felix Maldonado, Frank L Cordova, Frederick L Fricke, Gerald Feldman, Gerald M Feldman, PhD, Gerard Pde Leon, Gerard T Schneider, Ginger M Sykes, Grace Deneke, Grace E Mcnally, Guerlain Ulysse, Hanna L Potter, Haroon Vohra (NMI), Helen B Ricalde, Henry K Lau, Henry X Lau, Holly L Miller, Isabel Y Espinosa, Isaiah D Isakson, Jacqueline Mdiaz Albertini, James A Barreto, James D Bridges, James D Romero, James R Evans, James R Montero, Jamie L Dion, Jamie M Du, Janet Pulver, Janice L Straight, Javier O Vega, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer A Baker, Jennifer L Wolfe, Jennifer M Gogley, Jeremy W Rotton, Joan T Briones, Joey V Quitania, Jogy George, John A Gonzalez, Jose Acruz Gonzalez, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Jude C Dikes, Julie D Bringger, Junho Pak, Justin R Carr, Karen A Wolnik, Karen G Hirshfield, Katherine E Jacobitz, Katherine Szestypalow, Kathleen S Tormey, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Kelvin X Sanders, Kenneth V Miller, Kent C Faul, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Kimerley A Hoefen, Kristen E Szenderski, Lakisha M Williams, Lance M De Souza, MBA, Langer, Larisa E Pavlick, Lata C Mathew, PhD, Laura B Kennedy, Laura Fontan, MS, Laura L Van Wagenen, Laurie P Norwood, Lavender M Huskey, LCDR Jennifer H Rhyu, Lestine C Webb, Linda F Murphy, Linda M Cheny, Linda Thai, Linh Tu, Lisa Shin, Lori A Carr, Lucila B Nwatu, Mabel M Lee, Maida Henesian (NMI), Marc A Jackson, Jr, Marcus F Yambot, Margaret M Annes, Maria C Agpaoa, Maria C Fermin, Marie Bbuen Bigornia, Marie K Kinkade, Marion W Nadeau, Mariza M Jafary, Mark D Johnson, Marsha L Mccauley, Marsha W Major, Matthew J Hansen, Matthew R Clabeaux, Matthew R Dionne, Meisha R Sampson, Meisha Waters, Melissa F Chauvin, Michael A Charles, Michael J Kuchta, Michael Kuchta, Michael R Goga, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Miguel A Martinez, Mihaly S Ligmond, Min Shanma Liu, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nalini D Lebzelter, Nancy E Boocker, Nancy G Schmidt, Nathan M Jornod, Nathan R Moon, Nayan Patel, Neira Acevedo Ramos, Nicholas L Hunt, Nicholas Obiri, PhD, Oluwaseyi Ojinni, Omotunde O Osunsanmi, Pal S Mayasandra, Pankaj H Amin, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patrick E Gainer, Paul A Bonneau, Paul Mouris, Paul Z Balcer, Peter E Baker, Peter Kessler, PhD, Rafeeq A Habeeb, Rajiv R Srivastava, Raymond T Oji, Rebecca H Lee, Rebecca K Olin, Rebecca Rodriguez, Rebecca T Davis, Regina T Brown, Ricki A Chase, Ricki Achase Off, Riley C Myers, PhD, Robert C Coleman, Robert D Tollefsen, Robert Sharpnack, Roger F Zabinski, Rose M Ashley, Rumany C Penn, PharmD, Saied A Asbagh, Saleem A Akhtar, Salvatore N Randazzo, Samantha E Rafferty, Samina S Khan, Sandra S Saniga, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Scott N Lim, Serge Beaucage, Sheila Alaghemand, Shelley H Beausoleil, Shererk, Sherri J Jackson, Sidney B Priesmeyer, State Agency, Stephanie A Slater, MS, Stephen T Hansen, Steve P Yost, Stuart W Russell, Susan M Jackson, Susan P Bruederle, Taichun Qin, PhD, Tenzin Jangchup, Thai T Duong, Thao T Kwan, Thea C Grome, Theressa B Smith, Thuy T Nguyen, LCDR, Timothy C Grome, Tonia F Bernard, Tracy K Li, Trevor R Beach, Tricia S Martinez, Trinidad D Barreras, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Vicky L Cruz, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Virginia L Sheldon, Walden H Lee, William J Leonard, William V Millar, Xiaokuang Lai, PhD, Yasamin Ameri, Yi Wang, PhD, Yiyue Zhang (nmi), PhD, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Nayan J Patel's Documents

Publish Date Document Type Title
February, 2019 FDA 483 Response Corden Pharma Colorado, Inc. - Form 483R, 2019-02-20
January, 2017 FDA 483 In Your Atmosphere Holdings LLC - Form 483, 2017-01-19
December, 2018 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2018-12-10
January, 2018 FDA 483 Energy Los Alamos Office, United States Department of - Form 483, 2018-01-05
August, 2017 EIR Fresenius Medical Care North America - EIR, 2017-08-18
March, 2018 FDA 483 Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy - Form 483, 2018-03-13
May, 2017 EIR Church & Dwight Co., Inc. - EIR, 2017-05-24
September, 2019 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2019-09-20
December, 2017 FDA 483 Cody Laboratories, Inc. - Form 483, 2017-12-08
February, 2020 EIR Haupt Pharma Wolfratshausen GmbH - EIR, 2020-02-14
December, 2015 FDA 483 Thatcher Company - Form 483, 2015-12-10
October, 2015 FDA 483 Sandoz Incorporated - Form 483, 2015-10-30
June, 2021 FDA 483 Florida Cirtech Inc - Form 483, 2021-06-08
March, 2019 FDA 483 McGuff Pharmaceuticals, Inc. - Form 483, 2019-03-26
December, 2017 EIR Cody Laboratories, Inc. - EIR, 2017-12-08
June, 2019 FDA 483 Eisai Co., Ltd. - Form 483, 2019-06-28
August, 2020 FDA 483 Fresenius Medical Care North America - Form 483, 2020-08-13
September, 2019 FDA 483 Yusef Manufacturing Laboratories, LLC DBA YMlabs, LLC - Form 483, 2019-09-13
February, 2019 EIR Corden Pharma Colorado, Inc. - EIR, 2019-02-06
March, 2019 FDA 483 Response McGuff Pharmaceuticals, Inc. - Form 483R, 2019-04-16
August, 2017 FDA 483 Fresenius Medical Care North America - Form 483, 2017-08-18
February, 2023 FDA 483 Genentech, Inc. - Form 483, 2023-02-02
March, 2017 FDA 483 Isomeric Pharmacy Solutions, LLC - Form 483, 2017-03-24
October, 2017 EIR Actavis Laboratories UT, Inc. - EIR, 2017-10-25
July, 2019 FDA 483 Beijing HKKY Medical Tech. Co., Ltd. - Form 483, 2019-07-12
April, 2017 EIR Airgas Usa, LLC - EIR, 2017-04-28
November, 2019 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2019-11-22
January, 2020 FDA 483 Ultradent Products, Inc. - Form 483, 2020-01-17
February, 2018 FDA 483 Natural Health Supply - Form 483, 2018-02-06
February, 2023 FDA 483 Genentech, Inc. - Form 483, 2023-02-02
April, 2018 FDA 483 Optum Compounding Services, LLC - Form 483, 2018-04-20
March, 2020 FDA 483 Front Range Laboratories, Inc. - Form 483, 2020-03-20
August, 2017 FDA 483 Response Fresenius Medical Care North America - Form 483R, 2017-09-06
April, 2017 FDA 483 Airgas Usa, LLC - Form 483, 2017-04-28
February, 2019 FDA 483 Corden Pharma Colorado, Inc. - Form 483, 2019-02-06
October, 2019 FDA 483 Airgas Usa, LLC - Form 483, 2019-10-25

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more